TL;DR
- •Therapy (specifically CBT) and antidepressant medication produce comparable response rates in mild-to-moderate depression — both around 50-60%.
- •For severe depression, medication or the combination of medication + therapy outperforms therapy alone.
- •Therapy has lower relapse rates after treatment ends; medication has faster initial onset.
- •Combination therapy (medication + CBT together) outperforms either alone in most studies — not always available or affordable, but it's the strongest single approach.
- •Therapy doesn't carry medication side effects (sexual dysfunction, weight gain, sleep changes) but requires time, money, and access to a qualified therapist.
- •For treatment-resistant cases where multiple medications and/or therapy haven't worked, ketamine's rapid-acting mechanism becomes a relevant third option.
Side by side
Therapy (CBT, DBT, EMDR)
Evidence-based psychotherapy
Non-pharmacological intervention
What it treats
Depression, Anxiety disorders, PTSD, OCD, Eating disorders
Mechanism
Skills-based and insight-based interventions that change patterns of thinking, behavior, and emotional regulation. CBT targets cognitive distortions and behavioral activation; DBT adds emotion regulation and distress tolerance; EMDR processes traumatic memories.
Strengths
- •No medication side effects
- •Lower relapse rates after treatment ends (skills persist)
- •Addresses root causes, not just symptom suppression
- •No drug interactions or contraindications
- •Patient maintains agency over their treatment
Limitations
- •Requires 12-20+ weekly sessions for measurable benefit
- •Cost ($100-300/session) and insurance coverage varies
- •Therapist quality and fit vary widely
- •Slower onset than medication
- •Requires patient effort between sessions
Medication
Antidepressant or anxiolytic pharmacotherapy
Pharmacological intervention
What it treats
Depression, Anxiety disorders, PTSD, OCD, Chronic pain (some)
Mechanism
Various — SSRIs/SNRIs block reuptake of serotonin (and norepinephrine), atypical antidepressants act on dopamine/melatonin/glutamate, anxiolytics on GABA. Each works on the underlying neurochemistry differently.
Strengths
- •Measurable response in 4-8 weeks
- •No weekly time commitment beyond pill-taking
- •Effective even when therapy access is limited
- •Particularly important for severe depression / suicidality
- •Can be combined with therapy for stronger effect
Limitations
- •Side effects (sexual dysfunction, weight gain, sleep changes, GI)
- •Higher relapse rate after discontinuation than therapy
- •4-8 weeks to evaluate; one-third don't respond adequately
- •Drug interactions and contraindications
- •Long-term use creates dependence on the medication
Which one for your situation?
If:
Mild-to-moderate depression, no prior treatment, you have time + resources for weekly therapy
Verdict:
Therapy first — comparable efficacy to medication, no side effects, lower relapse rate
If:
Severe depression, especially with suicidal ideation
Verdict:
Medication (often combined with therapy when stable) — therapy alone usually isn't enough for severe cases
If:
Cost or access is the main constraint
Verdict:
Medication — generic SSRIs are cheap; therapy with a qualified provider often isn't
If:
Specific trauma to process (PTSD)
Verdict:
EMDR or trauma-focused CBT, often alongside medication for acute symptom management
If:
You've tried medication and it didn't work / was intolerable
Verdict:
Add or switch to therapy; or consider mechanism-switch options like ketamine
If:
You've tried therapy and it didn't produce enough change
Verdict:
Add medication; combination therapy usually outperforms either alone
Where ketamine fits
Ketamine isn't a replacement for therapy or first-line medication — it's a different category. The strongest use case is treatment-resistant depression: patients who have tried adequate trials of both medication AND therapy without sufficient response. Many ketamine patients continue therapy alongside ketamine treatment; the rapid antidepressant effect creates a "window of neuroplasticity" that may make therapy more effective.
Therapy: 12-20+ sessions for measurable benefit. Medication: 4-8 weeks. Sublingual ketamine: hours.
5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
Is therapy or medication better for depression?
For mild-to-moderate depression, they're comparable in efficacy. For severe depression, medication or the combination outperforms therapy alone. Therapy has lower relapse rates after treatment ends; medication has faster initial onset. The best evidence-based answer is usually combination therapy when feasible — medication for the biology, therapy for the patterns and skills.
Can I do both therapy and medication at the same time?
Yes — combination therapy is more effective than either alone in most studies. The medication addresses neurochemistry; therapy addresses cognitive patterns, behavioral activation, and skills. They're complementary, not competitive. Most clinicians recommend combination for moderate-to-severe depression when access allows.
If therapy didn't work, will medication?
Often yes. Therapy and medication act on different aspects of depression — biology vs cognition/behavior. Patients who don't respond to therapy alone frequently do respond to medication. The reverse is also true. After a fair therapy trial (12-20 weekly sessions), adding or switching to medication is a reasonable next step.
How does ketamine fit if I've tried both therapy and medication?
Ketamine is most strongly indicated for treatment-resistant depression — meaning multiple medication trials and adequate therapy haven't produced sufficient response. The mechanism (NMDA/glutamate) is entirely different from any conventional antidepressant or psychotherapy approach. Many ketamine patients continue therapy alongside ketamine sessions; the rapid antidepressant effect may make therapy more productive by opening a "neuroplasticity window."
Which has worse side effects?
Medication has measurable physical side effects (sexual dysfunction, weight gain, GI, sleep changes — varies by drug). Therapy doesn't have physical side effects but does require emotional work that can feel difficult — confronting patterns, sitting with discomfort, doing between-session homework. Different kinds of "cost" — neither is free, but the trade-offs are different.
References
- Cipriani A et al. 2018, Lancet. Network meta-analysis confirmed antidepressant efficacy in major depression at comparable rates to evidence-based psychotherapy in head-to-head studies. PMID 29477251
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus statement on ketamine as an option for patients who have failed both medication and therapy in treatment-resistant cases. PMID 28249076
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT in treatment-resistant depression — patients who had failed multiple prior treatments including therapy responded at 64% vs 28% placebo. PMID 23982301